Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patients
- 25 November 2023
- journal article
- research article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 84, 102271
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)International Journal of Antimicrobial Agents, 2021
- Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center studyCritical Care, 2020
- Overview of Pharmacological Considerations in Extracorporeal Membrane OxygenationCritical Care Nurse, 2019
- A Population Pharmacokinetic Analysis to Study the Effect of Extracorporeal Membrane Oxygenation on Cefepime Disposition in ChildrenPediatric Critical Care Medicine, 2019
- Incidence of nosocomial infections in adult patients undergoing extracorporeal membrane oxygenationHeart & Lung, 2018
- Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane OxygenationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2017
- β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case–control studyInternational Journal of Antimicrobial Agents, 2015
- The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort studyCritical Care, 2014
- Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenationJournal of Critical Care, 2012
- Pharmacokinetic Changes in Critical IllnessCritical Care Clinics, 2006